News & Articles

Scientific, technological and communications excellence has been celebrated at the Virtual Cancer and Immunology Research Summit, with Logos Biosystems, INTEGRA Biosciences and Sartorius among those recognized

Discover how collaborative research between big pharma and academia is using the latest proteomics platforms to revolutionize drug discovery

Explore topics from HRIM-MS for enhancing structural characterization to microbial monitoring, in situ hybridization and advances in fragrance profiling

Discover how to increase precision and reduce throughput time of your routine electrolyte analyses

Company rapidly expanding commercial operations to enable more researchers to extract higher yields of DNA and RNA from FFPE samples in one hour with minimal hands-on time

Catch up on this expert webinar to discover the customizable screening service helping to drive the validation of novel cancer therapies

Infectious disease expert shares how robust LC columns are facilitating the analysis of complex pathogen samples

Explore topics from LC-MS for oligos, peptides, glycans, and large molecule characterization to 3D cell culture for anticancer therapies

Dr. Raul Cano, Chief Scientific Officer at The BioCollective, discusses how to increase sequencing data accuracy and reproducibility and the future of the microbiome in healthcare

KSQ Therapeutics uses technology created at MIT to study the role of every human gene in disease biology

New, reversible CRISPR method can control gene expression while leaving underlying DNA sequence unchanged

First rapid antigen test with performance data on children

New image reconstruction algorithm enhances super-resolution microscope ZEISS Elyra 7

An insider’s view on leveraging the latest single-cell technologies, including cell sorting and single-cell sequencing, to understand what drives response or resistance in checkpoint therapies

Team dedicates the award to the scientists, healthcare professionals and scientific manufacturers who have risen to the challenges of the pandemic